Clinical Trial Update: Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial assessing brexpiprazole as an adjunctive treatment in elderly patients with major depressive disorder who had an inadequate response to antidepres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• brexpiprazole (brexpiprazole)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Major Depressive Disorder | Phase 3 | Status: TERMINATED | Results posted: 2016-03-03